|
|
|
|
T-003 / T-003-1ML updated item number format
(-)-Δ9-THC-D3
100 ug/mL in Methanol | Certified Reference Material
|
|
Δ9-THC is the main active constituent and the primary psychoactive cannabinoid of cannabis. Besides persistent illicit use this drug is suitable as treatment for anorexia and nausea and is sold under the trade name Marinol®. This Certified Spiking Solution® is suitable as an internal standard for quantitation of Δ9-THC levels in urine or other matrices by LC/MS or GC/MS for pharmaceutical research, clinical toxicology, or forensic testing applications.
|
|
|
|
|
| Concentration:
|
100 ug/mL
|
| Solvent:
|
Methanol
|
| Unit Size:
|
1 mL/ampoule
|
| CAS Number:
|
81586-39-2
|
| Chemical Formula:
|
C21H27D3O2
|
| Molecular Weight:
|
317.48
|
| Certificate of Analysis:
|
|
| US List Price:
|
|
|
|
|
| C-115 / C-115-1ML |
|
Cannabinol-D3, 100 μg/mL
|
|
$135.00
|
|
|
|
|
|
| C-140 / C-140-1ML |
|
Cannabidivarin (CBDV), 1.0 mg/mL
|
|
$240.00
|
|
|
|
|
|
| C-141 / C-141-1ML |
|
Cannabigerol (CBG), 1.0 mg/mL
|
|
$219.00
|
|
|
|
|
|
| C-142 / C-142-1ML |
|
Cannabigerolic acid (CBGA), 1.0 mg/mL
|
|
$240.00
|
|
|
|
|
|
| C-143 / C-143-1ML |
|
Cannabichromene (CBC), 1.0 mg/mL
|
|
$156.00
|
|
|
|
|
|
| C-144 / C-144-1ML |
|
Cannabidiolic acid (CBDA), 1.0 mg/mL
|
|
$240.00
|
|
|
|
|
|
| C-152 / C-152-1ML |
|
Cannabidivarinic Acid (CBDVA), 1.0 mg/mL
|
|
$260.00
|
|
|
|
|
|
| C-154 / C-154-1ML |
|
(±)-Cannabicyclol (CBL), 1.0 mg/mL
|
|
$260.00
|
|
|
|
|
|
| H-026 / H-026-1ML |
|
(±)-11-Hydroxy-Δ9-THC, 100 μg/mL
|
|
$82.00
|
|
|
|
|
|
| H-027 / H-027-1ML |
|
(±)-11-Hydroxy-Δ9-THC, 1.0 mg/mL
|
|
$253.00
|
|
|
|
|
|
| H-041 / H-041-1ML |
|
(±)-11-Hydroxy-Δ9-THC-D3, 100 μg/mL
|
|
$133.00
|
|
|
|
|
|
| T-004 / T-004-1ML |
|
(±)-11-nor-9-Carboxy-Δ9-THC-D3, 100 μg/mL
|
|
$46.90
|
|
|
|
|
|
| T-005 / T-005-1ML |
|
(-)-Δ9-THC, 1.0 mg/mL
|
|
$37.20
|
|
|
|
|
|
| T-006 / T-006-1ML |
|
(±)-11-nor-9-Carboxy-Δ9-THC (Racemic mixture - not to be used for immunoassay), 100 μg/mL
|
|
$38.80
|
|
|
|
|
|
| T-007 / T-007-1ML |
|
(±)-11-nor-9-Carboxy-Δ9-THC-D9, 100 μg/mL
|
|
$54.60
|
|
|
|
|
|
| T-008 / T-008-1ML |
|
(±)-11-nor-9-Carboxy-Δ9-THC-D3, 1.0 mg/mL
|
|
$264.00
|
|
|
|
|
|
| T-010 / T-010-1ML |
|
(±)-11-nor-9-Carboxy-Δ9-THC (Racemic mixture - not to be used for immunoassay), 1.0 mg/mL
|
|
$311.00
|
|
|
|
|
|
| T-011 / T-011-1ML |
|
(-)-Δ9-THC-D3, 1.0 mg/mL
|
|
$680.00
|
|
|
|
|
|
| T-018 / T-018-1ML |
|
(-)-11-nor-9-Carboxy-Δ9-THC (Suitable for use with immunoassay), 100 μg/mL
|
|
$44.10
|
|
|
|
|
|
| T-019 / T-019-1ML |
|
(-)-11-nor-9-Carboxy-Δ9-THC (Suitable for use with immunoassay), 1.0 mg/mL
|
|
$167.00
|
|
|
|
|
|
| T-038 / T-038-1ML |
|
(+)-11-nor-9-Carboxy-Δ9- THC glucuronide, 100 μg/mL
|
|
$311.00
|
|
|
|
|
|
| T-047 / T-047-1ML |
|
(±)-Δ9-THC (For Qualitative Use Only), 100 μg/mL
|
|
$186.00
|
|
|
|
|
|
| T-080 / T-080-1ML |
|
(±)-cis-11-Nor-9-carboxy-Δ9-THC-D3 glucuronide, 100 μg/mL
|
|
$387.00
|
|
|
|
|
|
| T-093 / T-093-1ML |
|
Δ9-Tetrahydrocannabinolic acid A (THCA-A), 1.0 mg/mL
|
|
$208.00
|
|
|
|
|
|
| T-094 / T-094-1ML |
|
Tetrahydrocannabivarin (THCV), 1.0 mg/mL
|
|
$296.00
|
|
|
|
|
Regulatory Control
▶ USDEA exempt chemical preparation - no USDEA registration or paperwork required
▶ Canada Test Kit Registration # 61-1538 - no Health Canada import authorization required
read more about ordering regulated substances
UN Number, Class, PG
1230, 3, II
Safety Data Sheet
HS Code
2845.90.0100
|
▶ A Validated Chiral HPLC Method for Resolution of ?8 and ?9 – Tetrahydrocannabinol Enantiomers | Tamara Tarbox, Isil Dilek PhD, Uma Sreenivasan PhD, Kenan Yaser, Cerilliant, 2009
|
|
▶ Confirmation and Quantitation of THC in Oral Fluid | Eric Chi, Jason Cole, Thermo Fisher Scientific, 2010
|
|
▶ Evaluation of LCMSMS Deuterium Scrambling in Clinically Significant Small Molecules | Joshua Cooper, Isil Dilek, and Uma Sreenivasan, Cerilliant, 2012
|
|
▶ GC Analysis of Tetrahydrocannabinol (THC) and Carboxytetrahydrocannabinol (THCCOOH) in Surface Water on SLB®-5ms after SPME using 50/30 µm DVB/Carboxen/PDMS Fiber, On-Fiber Derivatization | Sigma-Aldrich, 2016
|
|
▶ Investigation of the Impurities in Dronabinol Samples by LCMS | Huahua Jian, Isil Dilek, Uma Sreenivasan, Kenan Yaser, Cerilliant, 2010
|
|
|
|
|